Hepatic lesion characterization in cirrhosis: significance of arterial hypervascularity on dual-phase helical CT

H M Lee1, D S Lu, R M Krasny

  • 1Department of Radiological Sciences, UCLA Medical Center 90095, USA.

Insights

The presence of arterial hypervascularity in liver lesions of cirrhotic patients is a strong indicator of hepatocellular carcinoma (HCC). Dual-phase helical CT can accurately identify these hypervascular lesions, improving diagnostic confidence.

Area of Science:

  • Hepatology
  • Radiology
  • Oncology

Background:

  • Cirrhosis significantly increases the risk of developing liver cancer.
  • Accurate diagnosis of hepatic lesions in cirrhotic patients is crucial for treatment planning and prognosis.

Purpose of the Study:

  • To assess the diagnostic value of arterial hypervascularity on dual-phase helical CT for identifying malignant liver lesions in cirrhotic patients.
  • To correlate the presence and pattern of hypervascularity with histopathologic findings.

Main Methods:

  • Prospective identification of 58 liver lesions (>1 cm) in 26 cirrhotic patients undergoing preoperative evaluation for liver transplantation.
  • Retrospective review of dual-phase helical CT arterial phase scans to categorize lesions based on arterial hypervascularity.
  • Correlation of radiologic findings with histopathologic or clinical diagnoses.

Main Results:

  • Arterial hypervascularity was present in 37 of 58 lesions, all of which were hepatocellular carcinoma (HCC) (100% positive predictive value).
  • Of the 21 hypovascular lesions, 17 were HCC and 4 were benign (81% positive predictive value).
  • The presence of arterial hypervascularity was a statistically significant predictor of HCC (p < .05).

Conclusions:

  • The presence of hypervascularity in hepatic masses in cirrhotic patients is highly predictive of malignancy, specifically HCC.
  • Dual-phase helical CT is a valuable tool for diagnosing HCC in this patient population.
  • Arterial hypervascularity patterns did not correlate with histologic grading.
Abstract

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...